Risedronate Sodium
Pricing Report NDC 0591-3876-04

Latest NADAC: $32.01614 per EA · Effective May 22, 2019 · Est. package price $128.06 (4 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Risedronate Sodium (NDC 0591-3876-04) is $32.01614 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 22, 2019.

As a provided by Actavis Pharma, Inc., this medication is distributed in a 4 TABLET, DELAYED RELEASE in 1 DOSE PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$32.01614
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
May 22, 2019
Billable Units
4 EA
Estimated Package Price
$128.06
Data Status
As of May 29, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0591-3876-04
Description
4 TABLET, DELAYED RELEASE in 1 DOSE PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2015, the NADAC wholesale price for (NDC ) has moved within a range of $27.12350 to $40.43731 per EA. Over this 3 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$27.1235 - $40.4373
Market Volatility
49.09% Variance
Latest Trend
17.59%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 22, 2019 $32.01614 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2019 $27.22679 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2019 $27.22679 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 20, 2019 $27.72750 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 23, 2019 $27.12350 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $28.99700 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2018 $34.69571 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $30.26361 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 21, 2018 $33.35269 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 21, 2018 $33.35269 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 21, 2018 $34.38417 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2018 $33.78938 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026